skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

About Brenda

New York, {6D506EDE-F0E4-4964-93FF-D8A3DA23BDA0}

+38 year(s) experience

Brenda writes breaking news stories and feature articles about all areas of the biopharmaceutical industry with a focus on litigation, patents and intellectual property issues, and regulatory policies of the Food and Drug Administration, including biosimilars development. 
Brenda worked at the Pink Sheet and a sibling publication from 1981 to 1993, returning in 2007. In between she was a reporter for America Lawyer Magazine and a daily legal newspaper in San Francisco where she won several awards, including first place in investigative reporting for the first story ever written about patent trolls. This experience has given her an expertise in legal and regulatory issues.  She covers all aspects of FDA, including advisory committee meetings and drug approvals, and legal issues, including patent suits, Supreme Court cases, and government investigations. An amateur photographer, Brenda enjoys including photos with articles.

Analyst Articles

Articles by Brenda